Search research articles
Contact Us
Filters
Showing results (91-100 of 94) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 94 results.
Journal of Medicinal Chemistry
|
September 10, 1999
Sulfonamidopyrrolidinone factor Xa inhibitors: potency and selectivity enhancements via P-1 and P-4 optimization
Y M Choi-Sledeski, D G McGarry, D M Green, et al.
Plos One
|
May 17, 2018
Multi-site evaluation of the LN34 pan-lyssavirus real-time RT-PCR assay for post-mortem rabies diagnostics
Crystal M Gigante, Lisa Dettinger, James W Powell, et al.
Wellcome Open Research
|
June 5, 2020
Rapid in-country sequencing of whole virus genomes to inform rabies elimination programmes
Kirstyn Brunker, Gurdeep Jaswant, S M Thumbi, et al.
The Lancet Regional Health. Western Pacific
|
May 23, 2022
Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial
Thuy P Nguyen, Quyet Do, Lan T Phan, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 94) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 94 results.
Journal of Medicinal Chemistry
|
September 10, 1999
Sulfonamidopyrrolidinone factor Xa inhibitors: potency and selectivity enhancements via P-1 and P-4 optimization
Y M Choi-Sledeski, D G McGarry, D M Green, et al.
Plos One
|
May 17, 2018
Multi-site evaluation of the LN34 pan-lyssavirus real-time RT-PCR assay for post-mortem rabies diagnostics
Crystal M Gigante, Lisa Dettinger, James W Powell, et al.
Wellcome Open Research
|
June 5, 2020
Rapid in-country sequencing of whole virus genomes to inform rabies elimination programmes
Kirstyn Brunker, Gurdeep Jaswant, S M Thumbi, et al.
The Lancet Regional Health. Western Pacific
|
May 23, 2022
Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial
Thuy P Nguyen, Quyet Do, Lan T Phan, et al.
Page
of 10